Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study
Vascular Health and Risk Management · 2025
DOI: 10.2147/vhrm.s550388 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Vascular Health and Risk Management, 2025. Verfasst von Bin Jia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center fo…. Hauptthemen laut MEDLINE: Rivaroxaban, Neoplasms, Catheterization, Central Venous, Factor Xa Inhibitors. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Thromboseprophylaxe, Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Lung Cancer, Tianjin Lung Cancer Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's C…
- Department of Medical Oncology, Tianjin Medical University General Hospital, Heping, Tianjin, People's Republic of China.
ORCID-Profile: Bin Jia
Zitieren
APA
Jia, B., Lv, H., Gong, T., Wang, X., Ma, Q., Ren, Y., Zhang, L., & Zhong, D. (2025). Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study. Vascular Health and Risk Management. https://doi.org/10.2147/vhrm.s550388
Vancouver
Jia B, Lv H, Gong T, Wang X, Ma Q, Ren Y, et al. Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study. Vascular Health and Risk Management. 2025. doi:10.2147/vhrm.s550388
BibTeX
@article{Jia2025,
author = {Jia, Bin and Lv, Hui and Gong, Ting and Wang, Xin and Ma, Qing and Ren, Yaoyao and Zhang, Linlin and Zhong, Diansheng},
title = {Evaluating Rivaroxaban for Thromboprophylaxis in Cancer Patients with Long-Term Venous Access Devices: A Retrospective Cohort Study},
journal = {Vascular Health and Risk Management},
year = {2025},
doi = {10.2147/vhrm.s550388}
}
EUVIMED